Cargando…
Toll-Like Receptor Ligand-Based Vaccine Adjuvants Require Intact MyD88 Signaling in Antigen-Presenting Cells for Germinal Center Formation and Antibody Production
Vaccines are critical in the fight against infectious diseases, and immune-stimulating adjuvants are essential for enhancing vaccine efficacy. However, the precise mechanisms of action of most adjuvants are unknown. There is an urgent need for customized and adjuvant formulated vaccines against immu...
Autores principales: | Mosaheb, Munir M., Reiser, Michael L., Wetzler, Lee M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334362/ https://www.ncbi.nlm.nih.gov/pubmed/28316602 http://dx.doi.org/10.3389/fimmu.2017.00225 |
Ejemplares similares
-
Beyond MyD88 and TRIF Pathways in Toll-Like Receptor Signaling
por: Piras, Vincent, et al.
Publicado: (2014) -
Evolution of Toll, Spatzle and MyD88 in insects: the problem of the Diptera bias
por: Lima, Letícia Ferreira, et al.
Publicado: (2021) -
Toll-Like Receptor Ligand Based Adjuvant, PorB, Increases Antigen Deposition on Germinal Center Follicular Dendritic Cells While Enhancing the Follicular Dendritic Cells Network
por: Lisk, Christina, et al.
Publicado: (2020) -
MyD88-dependent and independent pathways of Toll-Like Receptors are engaged in biological activity of Triptolide in ligand-stimulated macrophages
por: Premkumar, Vummidigiridhar, et al.
Publicado: (2010) -
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
por: Saikh, Kamal U.
Publicado: (2021)